Beyond Borders 2014 – Overview of the Biotechnology Landscape
DOI:
https://doi.org/10.2533/chimia.2014.840Keywords:
Biotechnology, Business angels, Life sciences, Medical technology, Venture capitalAbstract
The global biotechnology industry rebounded strongly in 2013. Public companies achieved double-digit revenue growth and there was a sharp rise in funds. Product successes have boosted revenues, drawn investors and motivated large companies to invest strongly in R&D. However, much of the industry's growth was driven by a relatively small group of commercial stage companies, increasing the urgency for the rest of the industry to achieve greater efficiency in their drug development efforts.Downloads
Published
2014-12-17
Issue
Section
Scientific Articles
License
Copyright (c) 2014 Swiss Chemical Society
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
[1]
J. Zürcher, Chimia 2014, 68, 840, DOI: 10.2533/chimia.2014.840.